surmount 5 tirzepatide vs Semaglutide: SURMOUNT-5 Results New GLP-1 clinical trial data

The landmark SUSTAIN clinical trial series evaluated semaglutide in thousands of patients with type 2 diabetes, providing data on various metabolic parameters including lipid profiles

Many insurers cover Ozempic and Mounjaro for diabetes, but coverage is spotty for their use in weight loss

In patients with coexisting obesity and risky drinking patterns, GLP1 therapy has been associated with modest decreases in alcohol intake alongside weight loss

J Intellect Disabil Res 1996

Rush Option : The option to rush your prescription to be received within 3-5 business days is available for an additional $50

What We See at Perfect B: Clinical Observations on GHK-Cu and NAD+ At our clinic in Doral, FL, GHK-Cu and NAD+ serve different patient profiles but frequently overlap